Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Rapid Micro Biosystems, Inc. before investing.

In this article, we go over a few key elements for understanding Rapid Micro Biosystems, Inc.’s stock price such as:

• Rapid Micro Biosystems, Inc.’s current stock price and volume
• Why Rapid Micro Biosystems, Inc.’s stock price changed recently
• Upgrades and downgrades for RPID from analysts
• RPID’s stock price momentum as measured by its relative strength

About Rapid Micro Biosystems, Inc. (RPID)

Before we jump into Rapid Micro Biosystems, Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, biologics, medical devices, and personal care products in the United States, Switzerland, Germany, Japan, and internationally. The company offers Growth Direct platform, which includes growth direct system, proprietary consumables, lab information management system connection software, and customer support and validation services. Its platform automates and modernizes the antiquated, manual microbial quality control (MQC), testing workflows for therapeutic modalities, such as biologics and cell and gene therapies, vaccines, and sterile injectables. The company also provides onsite technical training services. Its solutions are used in environmental monitoring, water, bioburden, and sterility release testing applications. In addition, the company offers RMBNucleus Mold Alarm software; and Growth Direct LIMS connection software. Rapid Micro Biosystems, Inc. was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. The company was incorporated in 2006 and is headquartered in Lexington, Massachusetts.

Want to learn more about Rapid Micro Biosystems, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Rapid Micro Biosystems, Inc..

Rapid Micro Biosystems, Inc.’s Stock Price as of Market Close

As of April 16, 2026, 3:18 PM, CST, Rapid Micro Biosystems, Inc.’s stock price was $2.230.

Rapid Micro Biosystems, Inc. is down 5.11% from its previous closing price of $2.350.

During the last market session, Rapid Micro Biosystems, Inc.’s stock traded between $2.180 and $2.490. Currently, there are approximately 44.62 million shares outstanding for Rapid Micro Biosystems, Inc..

Rapid Micro Biosystems, Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

Rapid Micro Biosystems, Inc. Stock Price History

Rapid Micro Biosystems, Inc.’s (RPID) price is currently down 1.76% so far this month.

During the month of April, Rapid Micro Biosystems, Inc.’s stock price has reached a high of $2.490 and a low of $2.070.

Over the last year, Rapid Micro Biosystems, Inc. has hit prices as high as $4.940 and as low as $2.010. Year to date, Rapid Micro Biosystems, Inc.’s stock is down 23.1%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Rapid Micro Biosystems, Inc. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of April 15, 2026, there were analysts who downgraded Rapid Micro Biosystems, Inc.’s stock and analysts who upgraded over the last month.

Additionally, you'll want to evaluate Rapid Micro Biosystems, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Rapid Micro Biosystems, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Rapid Micro Biosystems, Inc.’s current valuation based on AAII’s Value Grade is a D, which means it is considered to be Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Rapid Micro Biosystems, Inc. (RPID) by visiting AAII Stock Evaluator.

Relative Price Strength of Rapid Micro Biosystems, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of April 15, 2026, Rapid Micro Biosystems, Inc. has a weighted four-quarter relative price strength of -8.90%, which translates to a Momentum Score of 25 and is considered to be Weak.

Want to learn more about how Rapid Micro Biosystems, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Rapid Micro Biosystems, Inc. Stock Price: Bottom Line

As of April 16, 2026, Rapid Micro Biosystems, Inc.’s stock price is $2.230, which is down 5.11% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Rapid Micro Biosystems, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.